---
source_file: tmpk0bdd7ms.pdf
source_url: https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
doc_type: slides
title: AXA/2025/FY/Earnings presentation
tables: 55
parsed_at: '2026-07-22T09:02:35Z'
---

### Full Year 2025 Earnings Presentation February 26, 2026

### Full Year 2025 Earnings

[c. 1; p. 2]

###### Legal and cautionary statements

* Certain statements in this document are forward-looking, identified by words like "expects," "anticipates," "may," "plan," "target," "would," and "could".
* Statements regarding expected underlying earnings per share (UEPS) growth for 2026 are forward-looking and provide one-off guidance for the last year of the Group’s current strategic plan.
* Forward-looking statements are based on Management’s current views and intentions, are subject to change, and carry known and unknown risks and uncertainties outside AXA’s control that could cause actual results to differ materially.
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by law.
* This presentation refers to non-GAAP financial measures (APMs) used by Management for analyzing operating trends, financial performance, and position.
* Non-GAAP financial measures generally lack standardized meaning and may not be comparable to measures used by other companies.
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
* "Underlying earnings," UEPS, "underlying return on equity," "combined ratio," and "debt gearing" are APMs as defined by ESMA’s guidelines and AMF’s position statement.
* Reconciliations of APMs to IFRS financial statements and their calculation methodologies are provided in AXA’s 2025 Activity Report.
* AXA’s 2025 Activity Report is available on www.axa.com.
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to audit completion.

### Contents

[c. 2; p. 3]

###### Presentation contents and speakers

* FY25 Highlights are on p.04.
* Thomas Buberl is the Group CEO.
* FY25 Business Performance is on p.09.
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
* FY25 Financial Performance is on p.13.
* Alban de Mailly Nesle is the Group CFO.

## FY25 Highlights

[c. 3; p. 4]

###### Group CEO

* Thomas Buberl is the Group CEO.

### Full Year 2025 – Excellent performance

[c. 4; p. 5]

###### Financial performance highlights

* Revenues: +6% vs. FY24
* Underlying EPS: +8% vs. FY24
* ROE: 16% in FY25
* Solvency II ratio: 224% in FY25

[c. 5; p. 5]

###### Shareholder returns and outlook

* DPS growth: +8%
* Annual share buyback: EUR 1.25bn
* Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026

[c. 6; p. 5]

###### Full Year 2025 – Excellent performance

(1) Based on the dividend proposed by AXA's Board of Directors on February 25, 2026 and subject to approval by the Shareholders' Annual General Meeting to be held on April 30, 2026.

(2) Following AXA's Board of Directors' approval on February 25, 2026, and expected to commence as soon as reasonably practicable, subject to market conditions.

### Executing the plan on growth, margin and efficiency

[c. 7; p. 6]

###### Underlying earnings by FY

|   | FY24 | FY25 | Change |
| --- | --- | --- | --- |
| Underlying earnings | 8.1 | 8.4 | +6% |
| Underlying earnings excluding AXA IM |   |   | +9% |

[c. 8; p. 6]

###### Organic growth, profitability, and efficiency

* Top line growth: +6% organic.
* Growth balanced across lines: P&C +5%, Life +9%, Health +5%.
* Record profitability with further margin expansion in P&C and L&H.
* Improved efficiency.
* Continued investments in growth and technology for scaling the business.
* Consistent earnings growth while enhancing reserve prudence.

[c. 9; p. 6]

###### Executing the plan on growth, margin and efficiency

(1) Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.

### Diversified franchise, well positioned in an attractive industry

#### Secular trends fueling demand across businesses

[c. 10; p. 7]

###### Protection gaps and emerging risks

* Protection gaps and emerging corporate risks are secular trends fueling demand across businesses.
* Demographics are driving demand for private retirement and healthcare.

[c. 11; p. 7]

###### Share by segment

| Segment | Share |
| --- | --- |
| Life | 33% |
| Health | 17% |
| Large & Specialty | 17% |
| SME & Mid-market | 16% |
| Retail | 17% |

[c. 12; p. 7]

###### Secular trends fueling demand

* Secular trends are fueling demand across businesses.

#### Our right to win

[c. 13; p. 7]

###### Right to win

* Leading brand and high customer NPS
* Strong and diversified distribution
* Technical expertise in pricing and underwriting risks
* Scale offering a cost advantage

[c. 14; p. 7]

###### Our right to win

(1) Pie chart represents FY25 gross written premium split excluding AXA IM and holdings.

### Laying the foundation for the next plan

[c. 15; p. 8]

###### Strategic priorities

* Clear tech and AI roadmap
* Driving efficiency
* Enhancing capital allocation discipline
* Building resilience
* Confidence in sustaining earnings growth

## FY25 Business Performance

[c. 16; p. 9]

###### FY25 Business Performance

* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.

### Strong delivery across our businesses

[c. 17; p. 10]

###### Gross written premiums & Underlying earnings by geography

|   | Gross written premiums | Underlying earnings |
| --- | --- | --- |
| France (27% of total GWP 1 ) | +6% to €31bn | +7% to €2.2bn |
| Europe (38% of total GWP 1 ) | +6% to €43bn | +9% to €3.5bn |
| AXA XL (17% of total GWP 1 ) | +4% to €19bn | +9% to €1.9bn |
| Asia, Africa & EME-LATAM (18% of total GWP 1 ) | +13% to €20bn | +6% to €1.5bn |

(1) FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.

### P&C – Strong margins, confidence in sustaining growth

[c. 18; p. 11]

###### P&C GWP and earnings

* GWP: EUR 58bn
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty)
* Underlying earnings: +9% to EUR 5.9bn

[c. 19; p. 11]

###### Outlook by business segment

|   | 2025 | Beyond 2025 |
| --- | --- | --- |
| Retail and SME & Mid-market | Growing volumes while expanding margins | Investing to improve customer retention & expanding distribution footprint |
| AXA XL (Large & Specialty) | Profitable growth with stable margins | Capitalizing on attractive growth opportunities and continued cycle management |

[c. 20; p. 11]

###### Future strategic focus

* Continued progress on efficiency
* Higher investment income
* Data & AI to further enhance customer experience & technical excellence

[c. 21; p. 11]

###### P&C – Strong margins, confidence in sustaining growth

(1) Includes AXA XL Re premiums of €2.6bn.

(2) Change FY25 vs. FY24 at constant FX.

### L&H – Good momentum, well positioned to capture growth opportunities

[c. 22; p. 12]

###### GWP by short-term and long-term

| Short-term |   |
| --- | --- |
| Long-term — Total GWP | €57bn |

[c. 23; p. 12]

###### Underlying earnings

* Underlying earnings +7% to EUR 3.5bn

#### 2025 Beyond 2025

[c. 24; p. 12]

###### Strategic priorities

* Long-term business: Accelerating net flows in Savings at attractive margins.
* Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for customers.
* Short-term business: Growing technical results while absorbing Mexico VAT impact.
* Short-term business: Capitalizing on demand for health & protection while further improving margins.
* Focus on cost reduction.
* Increasing penetration of Protection riders in Savings offerings.
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health.

[c. 25; p. 12]

###### 2025 Beyond 2025

(1) 1. Change FY25 vs. FY24 at constant FX.

## FY25 Financial Performance

[c. 26; p. 13]

###### Group CFO

* Alban de Mailly Nesle is the Group CFO.

### P&C – Continued disciplined growth

[c. 27; p. 14]

###### Currency notation

* All figures are in EUR billion.

#### GWP & Other Revenues

[c. 28; p. 14]

###### GWP & other revenues by segment

| Segment | FY24 | FY25 | Change | o/w pricing 1 | o/w volume 2 |
| --- | --- | --- | --- | --- | --- |
| Commercial lines |   | 35.8 | +4% | +2% | +2% |
| AXA XL Reinsurance |   | 2.6 | +8% | +0.3% | +7% |
| Retail lines |   | 19.7 | +7% | +5% | +2% |
| Total | 56.5 | 58.0 | +5% |   |   |

[c. 29; p. 14]

###### Commercial lines growth drivers

* Continued pricing momentum and volume growth in Mid-market and SME
* Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)

[c. 30; p. 14]

###### GWP & Other Revenues

(1) Price effect.

(2) Includes exposure adjustments and mix & other effects.

### P&C – Delivering further margin expansion while enhancing reserve prudence

#### Combined ratio

[c. 31; p. 15]

###### Combined ratio

|   | FY24 | FY25 |
| --- | --- | --- |
| Combined ratio | 91.0% | 90.6% |
| Undiscounted CY loss ratio (ex Nat Cat) | 67.4% | 67.0% |
| Expense ratio | 25.0% | 24.8% |
| Nat Cat | 3.8% | 3.4% |
| Prior year reserve development | -1.6% | -1.1% |
| Discount | -3.6% | -3.5% |

[c. 32; p. 15]

###### Combined ratio drivers

* Undiscounted current year loss ratio improved, excluding Nat Cat.
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
* AXA XL Insurance margins stable at attractive levels due to disciplined cycle management.
* Expense ratio improved due to efficiency measures, while investing in growth initiatives and technology.

[c. 33; p. 15]

###### Nat Cat and reserve development

* Nat Cat charges were below the normalized load.
* Lower reliance on prior year reserve development.
* Reserve prudence enhanced during a favorable year.

### P&C – Earnings growth from higher underwriting and financial result

[c. 34; p. 16]

###### P&C earnings overview

* P&C earnings increased by EUR 0.2bn to EUR 4.2bn.
* This growth was driven by higher underwriting results and a higher financial result.

[c. 35; p. 16]

###### Underlying earnings by step

| Step | Value |
| --- | --- |
| FY24 | 5,510 |
| Volume growth ( Underwriting result 1 ) | +292 |
| Margin improvement | +189 |
| Investment income ( Financial result) | +435 |
| Insurance finance expenses | -235 |
| Tax | -169 |
| Affiliates, FX & other | -150 |
| FY25 | 5,872 |

[c. 36; p. 16]

###### P&C earnings growth drivers

* P&C earnings grew +9%.
* Growth driven by a better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence.
* Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets.
* Higher unwind of discount of claims reserves, in line with guidance.
* Unfavorable forex impact notably due to USD depreciation vs. EUR.

[c. 37; p. 16]

###### P&C – Earnings growth from higher underwriting and financial result

(1) Underwriting result includes expenses.

### Life & Health – Strong growth in premiums, positive net flows

[c. 38; p. 17]

###### Life & Health premiums and net flows

* Life & Health premiums: EUR 49.1bn (+7% LFL)
* Life & Health net flows: EUR +0.2bn

[c. 39; p. 17]

###### Life GWP & other revenues by lines of business

|   | FY24 | FY25 | Growth |
| --- | --- | --- | --- |
| Total | 34.5 | 37.5 | +9% |
| Protection |   | 17.3 | +11% |
| Unit-Linked |   | 9.3 | +13% |
| Capital light G/A |   | 9.0 | +7% |
| Traditional G/A |   | 1.9 | -7% |

[c. 40; p. 17]

###### Health GWP & other revenues by individual and group

|   | FY24 | FY25 | Growth |
| --- | --- | --- | --- |
| Total | 17.5 | 19.0 | +5% |
| Individual |   | 10.5 | +6% |
| Group |   | 8.5 | +4% |

[c. 41; p. 17]

###### Net flows by segment

| Segment | Net flows |
| --- | --- |
| Protection | +4.9 |
| Health | +2.7 |
| Unit-Linked | +1.5 |
| Capital light G/A | +1.2 |
| Traditional G/A | -5.0 |

[c. 42; p. 17]

###### Employee Benefits premiums

* Employee Benefits premiums: EUR 12.9bn (+4% vs. FY24) at constant scope and FX.

[c. 43; p. 17]

###### Life & Health – Strong growth in premiums, positive net flows

(1) Including both short-term and long-term Employee Benefits GWP and other revenues.

### Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting

[c. 44; p. 18]

###### PVEP by business line

|   | FY24 | FY25 |
| --- | --- | --- |
| Protection & Health |   | 31.4 |
| Unit-Linked |   | 8.5 |
| Capital-light G/A |   | 7.8 |
| Traditional G/A |   | 1.7 |
| Total | 50.9 | 49.4 |
| Change | -2% | -2% |
| Protection & Health change | -4% | -4% |
| Unit-Linked change | +18% | +18% |
| Capital-light G/A change | -10% | -10% |
| Traditional G/A change | -10% | -10% |

[c. 45; p. 18]

###### NB CSM (pre-tax) by FY

| FY24 | FY25 |
| --- | --- |
| 2.2 | 2.2 |
| +3% | +3% |

[c. 46; p. 18]

###### NBV (post-tax) by FY

| FY24 | FY25 |
| --- | --- |
| 2.3 | 2.2 |
| stable | stable |
| NBV margin 4.4% | 4.5% |

[c. 47; p. 18]

###### Life & Health performance drivers

* PVEP was impacted by higher interest rates on discounting, despite strong growth in Life volumes.
* NB CSM was driven by robust Savings & Protection sales; reported growth was impacted by higher interest rates for discounting of future profits.
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.

[c. 48; p. 18]

###### Reporting basis

* All changes are at constant scope and FX.

### Life & Health – Growth in new business driving Normalized CSM growth

[c. 49; p. 19]

###### Financial Metrics

* All figures are in EUR billion.

#### Contractual Service Margin rollforward

[c. 50; p. 19]

###### Contractual Service Margin rollforward (In Euro billion)

| FY24 | New business CSM | Underlying return on in-force | CSM release | Economic variance | Operating variance | Affiliates, FX & other | FY25 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 33.6 | +2.2 | +1.3 | -3.0 | +0.6 | -0.3 | -1.4 | 33.0 |
| Normalized CSM growth +2% | Normalized CSM growth +2% | Normalized CSM growth +2% | Normalized CSM growth +2% | Normalized CSM growth +2% | Normalized CSM growth +2% | Normalized CSM growth +2% | Normalized CSM growth +2% |

[c. 51; p. 19]

###### CSM breakdown by business line

* Life CSM: EUR 25.4bn (FY25) vs EUR 25.8bn (FY24)
* Health CSM: EUR 7.6bn (FY25) vs EUR 7.7bn (FY24)

[c. 52; p. 19]

###### Normalized CSM growth and drivers

* Normalized CSM increased by +2%
* CSM release growth reflects better margins
* New business CSM growth was impacted by higher rates
* Economic variance reflects government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows, offset by a reduction in the duration of Group Life business in Switzerland
* FX impact mainly from JPY and HKD depreciation

[c. 53; p. 19]

###### Contractual Service Margin rollforward

(1) Change at constant scope and FX.

### Life & Health – Strong momentum in both short-term and long-term business

[c. 54; p. 20]

###### Life & Health gross revenues

* Gross revenues: EUR 32,009m in 2023 (reported)
  + France: EUR 10,009m
  + Europe: EUR 10,009m
  + AXA XL: EUR 1,000m
  + International: EUR 1,000m
  + Asia: EUR 10,000m
  + Other: EUR 0m

#### Underlying Earnings +7%

[c. 55; p. 20]

###### Underlying Earnings waterfall by Step

| Step | Value |
| --- | --- |
| FY24 | 3,323 |
| Short-term technical margin | +60 |
| Long-term result incl. CSM release | +156 |
| Financial result | -11 |
| Tax, FX and others | -27 |
| FY25 | 3,501 |

[c. 56; p. 20]

###### FY24 vs FY25 Underlying Earnings breakdown (In Euro million)

|   | FY24 | FY25 |
| --- | --- | --- |
| Short-term technical margin | 415 | 479 |
| Long-term result incl. CSM release | 2,680 | 2,804 |
| Financial result | 975 | 946 |
| Tax & others | -748 | -728 |

[c. 57; p. 20]

###### Underlying Earnings by Business Line

* Life underlying earnings: EUR 2.7bn (prior: EUR 2.6bn), +4% vs. FY24
* Health underlying earnings: EUR 0.8bn (prior: EUR 0.7bn), +17% vs. FY24

[c. 58; p. 20]

###### Technical Margin and Long-Term Results

* Strong short-term technical margin due to underwriting and claims initiatives
* Impact of legislative change on recoverability of value added tax in Mexico: -EUR 0.1bn
* Higher long-term results from +8% increase in CSM release
* Increase in CSM release reflects growth in reserve base, including from favorable equity market performance, and better margins

[c. 59; p. 20]

###### Underlying Earnings +7%

(1) Change at constant FX.

### Growth in net income reflecting higher earnings & the gain from the sale of AXA IM

[c. 60; p. 21]

###### Net income by business line

|   | FY24 | FY25 | Change |
| --- | --- | --- | --- |
| Property & Casualty | 5.5 | 5.9 | +9% |
| Life & Health | 3.3 | 3.5 | +7% |
| Asset Management | 0.4 | 0.2 | -57% |
| Holdings & other | -1.2 | -1.2 | - |
| Underlying earnings | 8.1 | 8.4 | +6% |
| Non-financial flows | -0.5 | +2.1 |   |
| o/w capital gains from AXA IM disposal | - | +2.2 |   |
| Financial flows (incl. RCG) | +0.3 | -0.7 |   |
| Net income | 7.9 | 9.8 | +26% |

[c. 61; p. 21]

###### Underlying earnings and holding costs

* Underlying earnings showed strong performance from insurance businesses.
* Holding cost was stable and is expected to remain at the current level in 2026.

[c. 62; p. 21]

###### Net income drivers

* Net Income was higher, mainly reflecting higher underlying earnings and the gain from the sale of AXA IM.
* Lower financial flows reflected an unfavorable forex impact.

#### Underlying earnings per share

[c. 63; p. 21]

###### Underlying earnings per share

* Underlying earnings per share are presented in EUR.

[c. 64; p. 21]

###### Underlying earnings per share (In Euro)

| FY24 | FY25 | Change |
| --- | --- | --- |
| 3.59 | 3.86 | +8% |

[c. 65; p. 21]

###### Underlying EPS growth drivers

* Underlying EPS growth included +6% from earnings growth.
* Underlying EPS growth included +3% from capital management.
* Underlying EPS growth included -2% from forex.
* Underlying EPS growth included -1% from temporary earnings dilution due to the timing of the anti-dilutive share buyback related to the AXA IM sale.

[c. 66; p. 21]

###### Underlying earnings per share

(1) Change at constant FX for underlying earnings and net income. Change on reported basis for underlying earnings per share.

### Shareholders' Equity

[c. 67; p. 22]

###### Shareholders' Equity

* Shareholders' Equity is presented in EUR billion.

#### Shareholders' equity

[c. 68; p. 22]

###### Shareholders' equity

|   | FY24 | HY25 | FY25 |
| --- | --- | --- | --- |
| SHE (excl. OCI) | 58.0 | 52.7 | 54.0 |
| Net OCI | -8.1 | -7.2 | -6.8 |
| Shareholders' Equity | 49.9 | 45.5 | 47.2 |
| SHE (excl. OCI & undated subordinated debt) | 53.2 | 47.0 | 49.4 |
| Debt gearing | 20.6% | 23.4% | 22.3% |
| Underlying ROE | 15.2% | 17.5% | 16.0% |

[c. 69; p. 22]

###### Shareholders' equity

|   | FY24 to FY25 | HY25 to FY25 |
| --- | --- | --- |
| Opening Shareholders' equity | 49.9 | 45.5 |
| Change in Net OCI | 1.3 | 0.4 |
| Net income for the period | 9.8 | 5.9 |
| Dividend | -4.6 | - |
| Annual share buyback | -1.2 | - |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 | -3.5 |
| Undated subordinated debt (including interest charges) | -0.3 | -1.2 |
| Forex | -3.5 | -0.1 |
| Other | -0.6 | 0.3 |
| Closing Shareholders' equity | 47.2 | 47.2 |

(1) Shareholders' equity Group share. Full Year 2025 Earnings

### Higher organic cash remittance and robust cash position at Holding

[c. 70; p. 23]

###### Currency notation

* All figures are in EUR bn.

#### Net Cash Remittance

[c. 71; p. 23]

###### Net Cash Remittance

|   | FY24 | FY25 |
| --- | --- | --- |
| Proceeds related to in-force treaties 2 | 0.6 |   |
| Ordinary remittance | 7.1 | 7.5 |
| Total | 7.7 | 7.5 |
| Remittance ratio 1 | 82% | 82% |

[c. 72; p. 23]

###### Net Cash Remittance

| FY24 Cash position | 4.0 |
| --- | --- |
| Net cash remittance from subsidiaries | +7.5 |
| Dividend | -4.6 |
| Annual share buyback | -1.2 |
| Anti-dilutive share buyback following the sale of AXA IM | -3.5 |
| Holding costs and interest expenses | -1.3 |
| Change in net debt | +1.6 |
| M&A and other | +3.1 |
| FY25 Cash position | 5.6 |

(1) Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.

(2) €0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.

### Solvency II at 224%

[c. 73; p. 24]

###### Foreseeable dividends and share buyback provision

* Foreseeable dividends: EUR -4.8bn
* Provision for annual share buyback for 2026: EUR -1.25bn

[c. 74; p. 24]

###### Eligible Own Funds (EOF) / Solvency Capital Requirement (SCR) / Solvency II ratio bridge FY24–FY25

|   | FY24 | Regulatory & model changes | Normalized capital generation | Operating variance | Economic variance & FX | Dividend & annual share buyback | Management actions, debt & other | FY25 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Eligible Own Funds (EOF) | 55.9 | +0.2 | +8.8 | -0.4 | -2.1 | -6.0 / -0.1 |   | 56.4 |
| Solvency II ratio | 216% | +0pt | +28pts | -1pt | +4pts | -24pts | +2pts | 224% |
| Solvency Capital Requirement (SCR) | 25.9 | 0.0 | +0.6 | 0.0 | -1.2 | 0.0 | -0.2 | 25.2 |

#### Key sensitivities

[c. 75; p. 24]

###### Solvency II ratio

* Solvency II ratio as of December 31, 2025: 224%

[c. 76; p. 24]

###### Impact by sensitivity

| Sensitivity | Impact |
| --- | --- |
| Interest rate +50bps | +2 pts |
| Interest rate -50bps | -1 pt |
| Corporate spreads +50bps | -1 pt |
| Euro Sovereign spreads +50bps 1 | -7 pts |
| Credit migration 2 | -4 pts |
| Listed Equity (excl. PE & Infra) +25% | -1 pt |
| Listed Equity (excl. PE & Infra) -25% | +2 pts |
| PE & Infra +25% | +14 pts |
| PE & Infra -25% | -19 pts |
| Inflation swap curve +50bps | -5 pts |

(1) Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).

(2) Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).

### Solvency II – impact of the end of grandfathering period and Solvency II revision

[c. 77; p. 25]

###### Solvency II Ratio and Capital Impacts

* Solvency II Ratio as of 31/12/2025: 224%
* Impact of the end of the grandfathering period on January 1, 2026: -10pts, reducing the ratio to 215%
* EUR 2.4bn of grandfathered debt will no longer be eligible as capital from January 1, 2026
* Impact of Solvency II revision, expected to come into effect in 1Q27: +17pts
* No change expected in organic capital generation
* Additional capital flexibility

## Conclusion

[c. 78; p. 26]

###### Group CEO

* Thomas Buberl is the Group CEO.

### Conclusion

[c. 79; p. 27]

###### Business performance and outlook

* Record results were achieved, at the top end of the target range, while enhancing reserve prudence.
* All businesses are

### Q&A

[c. 80; p. 28]

###### Date

* February 26, 2026

### AXA Investor Relations – Keep in touch

#### Meet our management

[c. 81; p. 29]

###### Investor calendar

* March: Roadshows in Europe and US
* May 5: 1Q25 Activity Indicators in Paris
* June 2: BNP Paribas Exane CEO Conference in Paris
* June 2-4: Goldman Sachs European Financials Conference in Zurich
* July 31: HY26 Earnings Release in Paris
* September 21: AXA Investor Day in London

#### Contact us

[c. 82; p. 29]

###### Investor Relations contact

* Investor Relations contact number: +33 1 40 75 48 42.
* Investor Relations email: investor.relations@axa.com.

#### Follow us

[c. 83; p. 29]

###### Website information

* AXA's website is www.axa.com.

## Appendices

### Contents

[c. 84; p. 31]

###### Additional disclosures

* Debt and Invested Assets are on p.31.
* Additional P&C disclosures are on p.36.
* Additional IFRS17 disclosures are on p.41.

### Gross financial debt and maturity breakdown as of December 31st, 2025

[c. 85; p. 32]

###### Gross financial debt and maturity breakdown as of December 31st, 2025

### Theme: Gross financial debt and

#### Gross financial debt Contractual maturity breakdown

[c. 86; p. 32]

###### Debt gearing

* Debt gearing was 20.6% (prior: 22.3%).

[c. 87; p. 32]

###### Gross financial debt by tier

|   | FY24 | FY25 | Jan 1st 2026 |
| --- | --- | --- | --- |
| Tier 1 | 4.8 | 4.6 | 3.2 |
| Tier 2 | 10.8 | 12.2 | 11.3 |
| Senior debt | 3.5 | 3.5 | 5.8 |
| Total | 19.2 | 20.3 | 20.3 |

[c. 88; p. 32]

###### Debt maturity and types

* The grandfathering period ends on January 1, 2026.
* EUR 0.4bn will be redeemed in January 2026.
* Debt types include Tier 1, Tier 2, and Senior debt.

[c. 89; p. 32]

###### Senior debt, Tier 2, Tier 1 by contractual maturity

|   | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Senior debt |   |   |   |   |   | 0.9 | 1.5 | 0.5 |   |
| Tier 2 |   |   |   | 0.5 |   | 0.7 | 10.8 | 4.6 |   |
| Tier 1 |   |   |   |   |   |   |   | 0.7 |   |

#### o/w Grandfathered debt (Contractual maturity breakdown)

[c. 90; p. 32]

###### o/w Grandfathered debt (Contractual maturity breakdown)

|   | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Tier 1 | - | - | - | - | - | - | - | - | 1.4 |
| Tier 2 | - | - | - | - | - | 0.7 | - | 0.2 | - |

#### Economic maturity breakdown

[c. 91; p. 32]

###### Economic maturity breakdown (In Euro billion)

|   | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Senior debt |   |   |   |   |   |   | 1.5 | 0.5 |   |
| Tier 2 |   | 0.1 | 2.4 | 0.5 | 2.0 | 0.4 | 6.4 | 0.7 |   |
| Tier 1 | 0.1 |   |   | 0.1 | 0.9 |   |   | 4.0 |   |

#### o/w Grandfathered debt (Economic maturity breakdown)

[c. 92; p. 32]

###### Grandfathered debt by economic maturity and tier

|   | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031-2039 | ≥2040 | Undated |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Tier 1 | - | 0.1 | - | 0.1 | - | - | 0.4 | - | 0.8 |
| Tier 2 | - | - | - | - | - | 0.7 | 0.2 | - | - |

(1,2) 1. Nominal debt. 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.

(3) 3. Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.

### General Account Invested Assets

[c. 93; p. 33]

###### General Account invested assets

* FY25 Total General Account invested assets
* Duration gap at -0.4 year

[c. 94; p. 33]

###### FY25 Total General Account invested assets: Euro 450 billion

| Fixed income | 77% |
| --- | --- |
| Real estate | 9% |
| Infrastructure equity | 2% |
| Listed equities | 2% |
| Private equity and hedge funds | 5% |
| Cash | 4% |
| Policy loans | 0% |

[c. 95; p. 33]

###### Invested assets (100%) In Euro billion

|   | FY25 | % |
| --- | --- | --- |
| Fixed income | 345 | 77% |
| o/w Government bonds | 167 | 37% |
| o/w Corporate bonds and loans | 121 | 27% |
| o/w Other fixed income 1 | 56 | 13% |
| Real estate | 41 | 9% |
| Infrastructure equity | 10 | 2% |
| Listed equities 2 | 10 | 2% |
| Private equity and hedge funds 3 | 23 | 5% |
| Cash | 19 | 4% |
| Policy loans | 2 | 0% |
| Total Insurance Invested Assets 4 | 450 | 100% |

(1) Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).

(2) Includes hedges. Listed equities excluding hedges at Euro 14 billion.

(3) Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).

(4) Please refer to the financial supplement for more details.

### Structured and Private Credit assets

[c. 96; p. 34]

###### Structured and Private Credit assets

| Invested assets (100%) In Euro billion | FY25 | % of total G/A 1 portfolio | Comments |
| --- | --- | --- | --- |
| Residential Mortgages | 16 | 4% | - €6bn Dutch mortgages, NHG guaranteed - €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) |
| CLO & ABS | 25 | 6% | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) |
| Infrastructure debt | 8 | 2% | - Skewed towards resilient industries (Telecom, Utilities, Transport) |
| CRE debt | 8 | 2% | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV |
| Mid-Market lending | 10 | 2% | - Strong diversification with €8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation |
| Other | 2 | 0% |   |
| Total Structured and Private Credit Assets | 69 | 15% | o/w 54% participating |

(1) G/A: General Account

### Investment portfolio – Fixed Income reinvestment

#### FY25 Fixed Income Reinvestment

[c. 97; p. 35]

###### FY25 fixed income reinvestment allocation

* EUR 57bn in fixed income reinvestment
* Government bonds & related: 32% of reinvestment, average rating AA
* Investment grade credit: 40% of reinvestment, average rating A
* ABS/CLO/IG fund financing: 21% of reinvestment
* Below investment grade credit: 7% of reinvestment

#### FY25 Fixed Income Reinvestment Yield

[c. 98; p. 35]

###### FY25 Fixed Income Reinvestment Yield

| Public fixed income 1 | Private & Structured fixed income 2 | Total fixed income |
| --- | --- | --- |
| 3.5% | 4.7% | 3.9% |

[c. 99; p. 35]

###### Fixed income investment details

* EUR 57bn fixed income invested at 3.9%
* Average duration of 9 years
* Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY)
* Gradual shift from alternative total return assets to Private & Structured credit

[c. 100; p. 35]

###### FY25 Fixed Income Reinvestment Yield

(1) Government and Corporate bonds and related.

(2) Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).

### Contents

[c. 101; p. 36]

###### Additional disclosures

* Debt and Invested Assets are detailed on p.31.
* Additional P&C disclosures are provided on p.36.
* Additional IFRS17 disclosures are available on p.41.

### AXA XL Insurance – Large Commercial & Specialty business

#### Well diversified across lines of business and geographies

[c. 102; p. 37]

###### FY25 GWP by line of business

* FY25 GWP by line of business: USD 19bn
  + Casualty: 35%
  + Property: 29%
  + Specialty: 19%
  + Professional lines: 17%

[c. 103; p. 37]

###### FY25 GWP by geography

* FY25 GWP by geography: USD 19bn
  + Americas: 46%
  + Europe & APAC: 35%
  + UK & Lloyds: 19%

#### Leading market positions across lines

[c. 104; p. 37]

###### Leading market positions

* Top 3 globally
* Multinational Programs
* Marine
* Fine Art & Specie

#### Managing the cycle to deliver consistent profitability

[c. 105; p. 37]

###### Commercial lines performance by segment

* Bubble chart axes: Ex-price growth (%) (x-axis) and Profitability (y-axis).
* Segments shown in the bubble chart:
  + Property: high profitability, high ex-price growth
  + Specialty
  + Casualty
  + Professional lines: lower profitability, lower ex-price growth

[c. 106; p. 37]

###### Managing the cycle to deliver consistent profitability

(1) Including Cyber

(2) Source: McKinsey

(3) Source: Aon, Guy Carpenter, and Global Market Insights

(4) Source: Industry Research Biz (January 2026)

### P&C – Focus on Reserves

#### Claims reserves ratio

[c. 107; p. 38]

###### Claims reserves ratio definition

* Claims reserves ratio is defined as Net undiscounted claims reserves divided by Net earned premiums.

[c. 108; p. 38]

###### Claims reserves ratio

|   | FY18 | FY19 | FY20 | FY21 | FY22 (IFRS4) | FY22 (IFRS17) | FY23 | FY24 | FY25 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Claims reserves ratio | 179% | 185% | 193% | 188% | 189% | 198% | 195% | 180% | 175% |

#### Technical reserves ratio

[c. 109; p. 38]

###### Net undiscounted technical reserves ratio

* The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums.

[c. 110; p. 38]

###### Technical reserves ratio

|   | FY18 | FY19 | FY20 | FY21 | FY22 (IFRS4) | FY22 (IFRS17) | FY23 | FY24 | FY25 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Technical reserves ratio | 213% | 227% | 233% | 226% | 227% | 234% | 232% | 216% | 210% |

(1) Includes net undiscounted claims reserves and unearned premium reserves.

### P&C – 2026 Simplified Group Nat Cat Reinsurance Program

[c. 111; p. 39]

###### Currency basis

* All figures are in Euro.

[c. 112; p. 39]

###### Capacity & Retention by peril

|   | EU Windstorm | Europe Flood | Europe Earthquake | NA Hurricane | NA Earthquake | Per other perils 3 | Reinsurance segment (illustrative) — Alternative Capital & Cat Bonds |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Capacity | 4.0bn | 2.1bn | 2.1bn | 1.2bn | 1.2bn |   |   |
| Retention | 600m | 450m | 400m | 600m 2 | 600m 2 | 400m |   |

[c. 113; p. 39]

###### 2026 Simplified Group Nat Cat Reinsurance Program

* Retention levels are expected to remain stable in 2026, consistent with 2025 levels.

[c. 114; p. 39]

###### P&C – 2026 Simplified Group Nat Cat Reinsurance Program

(1) Excludes local reinsurance covers;

(2) Varying retention between MX and NA (400m MX, 600m NA);

(3) Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.

### P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026

[c. 115; p. 40]

###### Nat Cat cost deviation

* Nat Cat cost deviation is presented in EUR billion, net of reinsurance.

#### Group underlying earnings deviation to average Nat Cat charges in 2026

[c. 116; p. 40]

###### Net of reinsurance

* The data is presented both net of reinsurance, post-tax, and net of reinsurance, pre-tax.

[c. 117; p. 40]

###### Deviation by scenario and percentile

| Scenario | Percentile | Deviation |
| --- | --- | --- |
| 1/20y more severe | 95th | €-1.2bn |
| 1/10y more severe | 90th | €-0.8bn |
| 1/5y more severe | 80th | €-0.4bn |
| Median | 50th | €+0.1bn |
| 1/5y less severe | 20th | €+0.5bn |
| 1/10y less severe | 10th | €+0.7bn |
| 1/20y less severe | 5th | €+0.8bn |

[c. 118; p. 40]

###### Nat Cat charges deviation

* Negative deviation in approximately 40% of cases for more severe years.
* Positive deviation in approximately 60% of cases for less severe years.

#### Average Expected Nat Cat charges

[c. 119; p. 40]

###### Amount & Estimated impact on GEP by year

|   | 2025 | 2026 |
| --- | --- | --- |
| Amount (€bn) | 2.6 | 2.7 |
| Estimated impact on GEP | ca. 4.5% | ca. 4.5% |

(1) Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings

### Contents

[c. 120; p. 41]

###### Additional disclosures

* Additional disclosures include Debt and Invested Assets on p.31.
* Additional P&C disclosures are on p.36.
* Additional IFRS17 disclosures are on p.41.

### P&C – Margin Analysis

#### Technical Result

[c. 121; p. 42]

###### Pre-tax technical result

* Pre-tax technical result in EUR million.

[c. 122; p. 42]

###### Current Accident Year Undiscounted Technical Margin by FY25

|   | FY25 | Change |
| --- | --- | --- |
| Current Accident Year Undiscounted Technical Margin | 2,778 | +707 |

[c. 123; p. 42]

###### Gross Earned Premiums and Current Accident Year Undiscounted Combined Ratio

| Gross Earned Premiums | 57,656 | +6% |
| --- | --- | --- |
| Current Accident Year Undiscounted Combined Ratio | 95.2% | -1.0pt |
| o/w Nat Cats | 3.4% | -0.4pt |

[c. 124; p. 42]

###### Current Accident Year Discounting

|   | FY25 | Change |
| --- | --- | --- |
| Current Accident Year Discounting | 2,009 | +115 |
| Discounting Ratio (in Combined Ratio points) | -3.5% | +0.0pt |
| Current Accident Year Net Claims reserves | €19.0bn |   |
| Duration | 4.0 years |   |
| Current Accident Year Discount rate | 2.8% |   |

[c. 125; p. 42]

###### Prior Years' Reserve Development (PYD)

|   | FY25 | Change |
| --- | --- | --- |
| Prior Years' Reserve Development (PYD) | 622 | -341 |
| PYD ratio | -1.1% | +0.7pt |

[c. 126; p. 42]

###### FY25 sensitivity to Current Accident Year discount rate changes

| +25bps | -25bps |
| --- | --- |
| €+0.2bn | €-0.2bn |

#### Financial Result

[c. 127; p. 42]

###### Pre-tax results

* All figures are in EUR million (pre-tax).

[c. 128; p. 42]

###### Investment Income

|   | FY25 | Change |
| --- | --- | --- |
| Investment Income | 3,988 | +435 |
| FY25 Average Assets | €115bn |   |
| Asset book yield | 3.5% |   |
| FY25 Reinvestment yield 1 | 4.3% |   |

[c. 129; p. 42]

###### Insurance finance expenses

|   | FY25 | Change |
| --- | --- | --- |
| Insurance Finance Expenses | -1,358 | -235 |
| FY24 Reserves at locked-in rate | €71bn |   |
| Liability book yield | 1.9% |   |

[c. 130; p. 42]

###### 2026e Insurance Finance Expenses (pre-tax) by change in 2025 current AY Discount

| +25bps | -25bps |
| --- | --- |
| ~ €-50m | ~€+50m |

[c. 131; p. 42]

###### Underlying earnings before tax, tax, affiliates, minority interests & other, and underlying earnings

|   | FY25 | Change |
| --- | --- | --- |
| Underlying Earnings before tax | 8,040 | +681 |
| Tax | -2,060 | -169 |
| Affiliates, Minority interests & Other | -108 | -10 |
| Underlying Earnings | 5,872 | +501 |
| Growth vs. FY24 (at constant FX) |   | +9% |

(1) Reinvestment yield on fixed income assets.

(2) Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve.

### L&H – Margin Analysis

[c. 132; p. 43]

###### Scope impact

* Includes scope impact.

#### Technical Result

[c. 133; p. 43]

###### Pre-tax technical result

* Pre-tax technical result (in EUR million):

[c. 134; p. 43]

###### Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio

|   | FY25 | Change |
| --- | --- | --- |
| Short-term Technical Margin | 479 | +60 |
| Gross Earned Premiums | 17,416 | +10% |
| All Year Combined Ratio | 97.2% | -0.1pts |

[c. 135; p. 43]

###### Laya recapture

* Includes recapture of Laya.

[c. 136; p. 43]

###### Long-term Technical Margin by CSM release and Technical experience

|   | FY25 | Change |
| --- | --- | --- |
| Long-term Technical Margin | 2,804 | +156 |
| CSM release | 2,954 | +215 |
| Technical experience | -150 | -58 |

[c. 137; p. 43]

###### FY25 CSM by interest rates, sovereign spreads, corporate spread, equities

| Baseline | 33.3 |
| --- | --- |
| Interest rates +50bps | -0.8 |
| Interest rates -50bps | 0.6 |
| Sovereign spreads +50bps | -1.9 |
| Sovereign spreads -50bps | 1.9 |
| Corporate spread +50bps | -0.8 |
| Corporate spread -50bps | 0.7 |
| Equities +25% | 1.8 |
| Equities -25% | -2.2 |

#### Financial Result

[c. 138; p. 43]

###### Pre-tax result by segment

* Pre-tax result: EUR 7,604m
  + France: EUR 2,000m
  + Europe: EUR 2,000m
  + AXA XL: EUR 1,500m
  + Asia: EUR 1,000m
  + International: EUR 500m
  + AXA IM: EUR 200m
  + Other: EUR 400m

[c. 139; p. 43]

###### Investment income (non-VFA only)

|   | FY25 | Change |
| --- | --- | --- |
| Investment Income (non-VFA only) | 2,484 | -1 |
| FY25 Average Assets | €98bn |   |
| Asset book yield | 2.5% |   |
| FY25 Reinvestment yield 1 | 3.8% |   |

[c. 140; p. 43]

###### Insurance Finance Expenses (non-VFA only)

|   | FY25 | Change |
| --- | --- | --- |
| Insurance Finance Expenses (non-VFA only) | -1,538 | -9 |
| FY24 Reserves at locked-in rate | €62bn |   |
| Liability book yield | 2.5% |   |

[c. 141; p. 43]

###### Underlying Earnings before tax, Tax, Affiliates, Minority interests & Other, Underlying Earnings

|   | FY25 | Change |
| --- | --- | --- |
| Underlying Earnings before tax | 4,229 | +205 |
| Tax | -800 | 65 |
| Affiliates, Minority interests & Other | 72 | -51 |
| Underlying Earnings | 3,501 | +219 |
| Growth vs. FY24 (at constant FX) |   | +7% |

(1) Reinvestment yield on fixed income assets.

### Contents

[c. 142; p. 44]

###### Additional disclosures

* Additional disclosures include Debt and Invested Assets.
* Additional disclosures include P&C disclosures.
* Additional disclosures include IFRS17 disclosures.

### Expanding AXA's role in society: AXA for Progress Index

[c. 143; p. 45]

###### 2025 Result by As a GLOBAL INVESTOR, As a GLOBAL INSURER, As a COMPANY

| As a GLOBAL INVESTOR Target | As a GLOBAL INVESTOR 2025 Result | As a GLOBAL INSURER Target | As a GLOBAL INSURER 2025 Result | As a COMPANY Target | As a COMPANY 2025 Result |
| --- | --- | --- | --- | --- | --- |
| €5bn 2 in climate transition financing per year | €6.4bn | €6bn 3 in P&C GWP to support transition underwriting (cumulative 2024-2026) | €4.6bn | >80,000 6 AXA Group employees trained on climate adaptation by 2026 | 46,420 |
| >€500m 2 in community resilience financing per year | €6.4bn | >20,000 4 climate adaptation solutions & services (cumulative 2024-2026) Target revised in 2025 | 19,698 Cumulative 2024-2025 | Contribute to Net-Zero -50% 7 by 2030 in absolute carbon emissions and offset of residual emissions 8 | -64% Reduction against 2019 |
|   | €1.4bn | >20m 5 inclusive insurance customers by 2026 | 20.6m | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 | 56% |

(1) AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026.

(2) Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.

(3) Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.

(4) Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Climate solutions & services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaption solutions & services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from >9,000 to >20,000.

(5) Low-income to mass market segments in emerging markets and modest income segments in mature markets.

(6) Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.

(7) Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.

(8) Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).

### Sustainability Performance & Ratings

[c. 144; p. 46]

###### Sustainability ratings

* S&P Global: 97th percentile in Dow Jones Best-in-Class Europe & World indices for 2025.
* MSCI: AAA score for 2025.
* CDP: B score for 2025.
* Morningstar Sustainalytics: ESG Risk Rating of 17.0 (Low risk) for 2025.
* FTSE Russell: 4.3/5 score in FTSE4Good Index Series for 2025.

[c. 145; p. 46]

###### Sustainability Performance & Ratings

(1) The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.

### Scope

[c. 146; p. 47]

###### Scope of activities by geography and segment

* France: includes insurance activities, banking activities, and holding.
* Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities).
* AXA XL: includes insurance and reinsurance activities and holding.
* Asia, Africa & EME-LATAM:
  + Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
  + Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, underlying earnings, and net income.
  + Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding) are fully consolidated.
  + EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
  + EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
  + AXA Mediterranean Holdings is included.
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
* AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated.
* AXA Investment Managers (until July 1, 2025): Asian joint ventures are consolidated under the equity method.

[c. 147; p. 47]

###### Accounting standards

* All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4.

### Glossary

[c. 148; p. 48]

###### Glossary of financial terms

* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%.
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders.
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period.
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force.
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow.
* Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business).
* Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities).
* New Business Value (NBV): the value of newly issued contracts during the current year, consisting of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period (carried by Life entities, considering expected renewals), (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes, and (vi) minority interests.
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP.
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes, net of reinsurance.
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term, discounted at the reference interest rate and representing the Group share.
* Technical experience: consists of the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses.
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance.

### Thank you Full Year 2025 Earnings February 26, 2026